Abstract: The present invention provides for novel and improved liraglutide precursor purification processes of liraglutide precursor using selective unit operation steps and selective pH gradients in the reversed phase-high performance liquid Chromatography, for purifying crude liraglutide precursor from closely related impurities.
| # | Name | Date |
|---|---|---|
| 1 | 202447014013-STATEMENT OF UNDERTAKING (FORM 3) [27-02-2024(online)].pdf | 2024-02-27 |
| 2 | 202447014013-PRIORITY DOCUMENTS [27-02-2024(online)].pdf | 2024-02-27 |
| 3 | 202447014013-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [27-02-2024(online)].pdf | 2024-02-27 |
| 4 | 202447014013-FORM 1 [27-02-2024(online)].pdf | 2024-02-27 |
| 5 | 202447014013-DRAWINGS [27-02-2024(online)].pdf | 2024-02-27 |
| 6 | 202447014013-DECLARATION OF INVENTORSHIP (FORM 5) [27-02-2024(online)].pdf | 2024-02-27 |
| 7 | 202447014013-COMPLETE SPECIFICATION [27-02-2024(online)].pdf | 2024-02-27 |
| 8 | 202447014013-Proof of Right [09-04-2024(online)].pdf | 2024-04-09 |
| 9 | 202447014013-FORM-26 [23-05-2024(online)].pdf | 2024-05-23 |
| 10 | 202447014013-FORM 18 [14-06-2025(online)].pdf | 2025-06-14 |